Consolidating resources
The Process Solutions Business Unit supplies products used to manufacture biopharmaceutical drugs. It accounts for about 40% of the division’s total revenues. The business unit enables pharmaceutical and biotechnology companies to develop and manufacture clinical and commercial drug materials safely and efficiently. By combining the resources of Millipore and Merck, we can expand our portfolio of integrated bioprocessing technologies and offer an attractive range of development and regulatory services to biopharmaceutical manufacturers.
Biological safety
Products offered by the Process Solutions Business Unit support clarification, purification, viral clearance, sterile filtration, process monitoring and process development through scale-up to full-scale production. The portfolio helps ensure biological safety, for example with products for sterile and virus filtration as well as hardware and support for downstream processing.
With a comprehensive range of products and services for purification, e.g. ultrafiltration and chromatography, Merck Millipore helps biopharmaceutical developers and manufacturers to efficiently and effectively purify biologic drugs. Some of the products within this portfolio include Pelicon® for tangential flow filtration, Millistak® Pod and Prostak ™ for clarification, ChromaSorb ™, and ProSep® chromatography media. The purification portfolio is complemented by Fractogel® and Eshmuno® from the Merck chromatography business.
Advanced separation technologies
The Mobius® single-use product line provides integrated solutions that bring together Merck Millipore’s advanced separation technologies, differentiated single-use products, applications expertise, and expert validation support. Mobius® FlexReady Solutions are optimized, complete single-use solutions that integrate process-ready hardware systems with Mobius® Flexware assemblies.
As it eliminates the time-consuming steps involved in cleaning, autoclaving and assembling, the Mobius® CellReady 3L single-use, stirred tank bioreactor considerably reduces the downtime typical of glass bioreactors. This enables process development engineers to focus more on experimentation and data analysis in order to obtain results faster.
Pharmaceutical excipients
Moreover, the business unit’s portfolio covers the entire pharmaceutical production value chain. Apart from regulated starting materials and active pharmaceutical ingredients, our pharmaceutical raw materials, for example from the Parteck® range, are used as excipients for the production of solid, semi-solid, and liquid formulations. Cell culture supplements complement the range of products and services for upstream processing. Merck has combined its range of excipients and active ingredients for pharmaceutical production processes under the Emprove® brand.
back
